Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
treatment crawled date : 2021 - 10 - 25 save search
European Commission Selects Humanigen’s Lenzilumab as One of the 10 Most Promising Treatments for COVID-19
Published: 2021-10-25 (Crawled : 18:00) - biospace.com/
HGEN | $0.0361 -61.5% 120M
|
Health Technology
|
| O: -0.93%
H: 12.58%
C: 3.77%
covid treatment europe lenzilumab covid-19
DICE Therapeutics Initiates Phase 1 Clinical Trial of S011806 for the Treatment of Psoriasis
Published: 2021-10-25 (Crawled : 13:00) - biospace.com/
DICE | $47.55 0.06% 0.08% 0
|
|
| O: 2.14%
H: 0.0%
C: -1.13%
psoriasis treatment phase 1 trial phase 2 phase 3
Aquestive Therapeutics Reports Positive Topline Data from Phase 1 Pharmacokinetic Trial of AQST-109 (epinephrine prodrug sublingual film) Supporting its Development as an Oral Alternative to Epinephrine Autoinjectors for the Emergency Treatment of Allergi
Published: 2021-10-25 (Crawled : 13:00) - aquestive.com
AQST | $4.325 -1.26% 1.2M
|
Health Technology
|
| O: 1.64%
H: 9.45%
C: 7.6%
treatment epinephrine phase 1 positive topline drug trial merge
Aquestive Therapeutics Reports Positive Topline Data from Phase 1 Pharmacokinetic Trial of AQST-109 (epinephrine prodrug sublingual film) Supporting its Development as an Oral Alternative to Epinephrine Autoinjectors for the Emergency Treatment of Allergic Reactions
Published: 2021-10-25 (Crawled : 13:00) - globenewswire.com
AQST | $4.325 -1.26% 1.2M
|
Health Technology
|
| O: 1.64%
H: 9.45%
C: 7.6%
treatment epinephrine phase 1 positive topline drug trial merge
Arrowhead Files for Regulatory Clearance to Begin Phase 1/2a Study of ARO-C3 for Treatment of Complement Mediated Diseases
Published: 2021-10-25 (Crawled : 12:00) - biospace.com/
ARWR | $24.25 1.38% 380K
|
Health Technology
|
| O: -0.69%
H: 1.61%
C: 0.11%
disease media treatment phase 1 phase 2 clearance
Merck Announces Positive Top-Line Results from Pivotal Phase 3 Trials Evaluating Investigational, Once-Daily Oral Fixed Dose Combination of Doravirine/Islatravir for the Treatment of People with HIV-1 Infection
Published: 2021-10-25 (Crawled : 12:00) - biospace.com/
MRK | $126.955 0.01% 3.7M
|
Health Technology
|
| O: -0.1%
H: 0.86%
C: 0.78%
treatment positive results trials phase 3 trial hiv topline injection infections
Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa in Combination With Pembrolizumab for the Treatment of Platinum-Resistant Ovarian Cancer
Published: 2021-10-25 (Crawled : 11:00) - investor.alkermes.com
ALKS | $24.48 1.7% 640K
|
Health Technology
|
| O: 2.22%
H: 2.22%
C: 2.15%
treatment fda fda fast track fast track cancer nemvaleukin ovarian cancer fast track designation designation
Merck and Ridgeback Announce Initiation of a Rolling Review by the European Medicines Agency for Molnupiravir, an Investigational Oral Antiviral Medicine, for the Treatment of COVID-19 in Adults
Published: 2021-10-25 (Crawled : 11:00) - biospace.com/
MRK | $126.955 0.01% 3.7M
|
Health Technology
|
| O: -0.1%
H: 0.86%
C: 0.78%
covid treatment molnupiravir europe antiviral
Bausch + Lomb and Clearside Biomedical Announce FDA Approval of XIPERE™ (triamcinolone acetonide injectable suspension) for Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis
Published: 2021-10-25 (Crawled : 11:00) - biospace.com/
BHC | $8.565 1.36% 1.2M
|
Health Technology
|
| O: 0.28%
H: 1.95%
C: 0.9%
CLSD | News P | $1.44 2.13% 190K
|
Health Technology
|
| O: 3.49%
H: 8.51%
C: -0.89%
treatment fda ema fda approval approval macular xipere injection
Short-Term Mental Health Treatments That Work
Published: 2021-10-25 (Crawled : 10:00) - brainsway.com
BWAY | $4.89 2.95% 13K
|
Health Technology
|
| O: -1.98%
H: 2.59%
C: 1.64%
treatment health
Long-Term vs. Short-Term Psychotherapy Treatments
Published: 2021-10-25 (Crawled : 10:00) - brainsway.com
BWAY | $4.89 2.95% 13K
|
Health Technology
|
| O: -1.98%
H: 2.59%
C: 1.64%
treatment therapy
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.56 162.07% 21M
|
AGBA | $2.74 119.2% 52M
|
Finance
CZOO | $9.07 81.76% 22M
|
EDBL | News | $6.56 74.47% 1.8M
|
MTC | $2.21 41.67% 5.6M
|
Technology Services
OPRT | News | $3.12 38.67% 11M
|
Finance
PALI | $6.59 33.67% 23M
|
Manufacturing
VNRX | $0.7945 32.42% 3.1M
|
Health Technology
MLEC | $1.81 29.29% 2.8M
|
n/a
BTCM | $3.45 27.78% 640K
|
Arts, Entertainment, and Recrea...
Your saved searches
Save your searches and get alerts when important news are released.